TRC4, an improved triptolide derivative, specifically targets to truncated form of retinoid X receptor-alpha in cancer cells. (Q38733232)
Jump to navigation
Jump to search
scientific article published on 31 October 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | TRC4, an improved triptolide derivative, specifically targets to truncated form of retinoid X receptor-alpha in cancer cells. |
scientific article published on 31 October 2016 |
Statements
TRC4, an improved triptolide derivative, specifically targets to truncated form of retinoid X receptor-alpha in cancer cells (English)
Pei-Yu Wang
Wen-Jun Zeng
Jie Liu
Yinghui Ma
Zhiping Zeng
Ji-Yan Pang
Xiao-Kun Zhang
Xiaomei Yan
Alice Sze Tsai Wong
Jin-Zhang Zeng
31 October 2016